Not Indolamine 2, 3 Dioxygenase Polymorphisms, But Low Levels of IDO And IDO2 Are Associated with Behçet’s Syndrome

• Published in: Medical principles and practice pp. 1 - 18
• Main Authors: Uçar, Ülkü, Aydin Atalay, Yağmur, Özkaya, Güven, Oral, Haluk Barbaros
• Format: Journal Article
• Language: English
• Published: 29.03.2025

Objective: Behçet’s syndrome (BS) is a multisystemic disorder with a complex genetic background. Indoleamine 2,3-dioxygenase (IDO) and IDO2, key enzymes in tryptophan metabolism, have immunomodulatory effects. Specific IDO and IDO2 polymorphisms may influence enzymatic activity. This study aimed to...